Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

NCT00139178 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

HIV Associated Lipodystrophy Syndrome.
HIV
Hypercholesterolemia
Lipoatrophy

Interventions

DRUG: Different HAART regimens

Sponsor

Danish HIV Research Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]